Across TCGA pan-cancer cohorts, OR1D4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR1D4 data layer compared with 6 for mutation status.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR1D4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR1D4 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.
BLCA, HNSC, and KICH are the cancer types where OR1D4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.